153 related articles for article (PubMed ID: 35892231)
1. LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of
Ge B; Zhang X; Zhou W; Mo Y; Su ZH; Xu G; Chen Q
Cell J; 2022 Jun; 24(6):294-301. PubMed ID: 35892231
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CDKN2B-AS1 promotes hepatocellular carcinoma progression
Tao ZG; Yuan YX; Wang GW
World J Gastrointest Oncol; 2023 Nov; 15(11):1974-1987. PubMed ID: 38077646
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor RELA promotes hepatocellular carcinoma progression by promoting the transcription of m6A modulator METTL3.
Wu J; Wang W; Zheng Y; Deng W; Liu J
Pathol Res Pract; 2024 Mar; 255():155168. PubMed ID: 38367599
[TBL] [Abstract][Full Text] [Related]
5. Transcription Factor E2F1 Enhances Hepatocellular Carcinoma Cell Proliferation and Stemness by Activating GINS1.
Ren X; Shen L; Gao S
J Environ Pathol Toxicol Oncol; 2024; 43(1):79-90. PubMed ID: 37824372
[TBL] [Abstract][Full Text] [Related]
6. LINC00704 contributes to the proliferation and accelerates the cell cycle of nasopharyngeal carcinoma cells via regulating ETS1/CDK6 axis.
Wang Y; Tan QY; Shen Y; Liu CY; Huang T; Huai D; Dai J
Kaohsiung J Med Sci; 2022 Apr; 38(4):312-320. PubMed ID: 34989116
[TBL] [Abstract][Full Text] [Related]
7. High glucose may promote the proliferation and metastasis of hepatocellular carcinoma via E2F1/RRBP1 pathway.
He Y; Huang S; Cheng T; Wang Y; Zhou SJ; Zhang YM; Yu P
Life Sci; 2020 Jul; 252():117656. PubMed ID: 32289433
[TBL] [Abstract][Full Text] [Related]
8. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
Tang C; Feng W; Bao Y; Du H
Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
11. CircWHSC1 serves as an oncogene to promote hepatocellular carcinoma progression.
Lyu P; Zhai Z; Hao Z; Zhang H; He J
Eur J Clin Invest; 2021 Jun; 51(6):e13487. PubMed ID: 33410156
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis.
Mu B; Lv C; Liu Q; Yang H
J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA CASC11 promotes hepatocarcinogenesis and HCC progression through EIF4A3-mediated E2F1 activation.
Song H; Liu Y; Li X; Chen S; Xie R; Chen D; Gao H; Wang G; Cai B; Yang X
Clin Transl Med; 2020 Nov; 10(7):e220. PubMed ID: 33252856
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MIAT promotes the proliferation, migration, and invasion of melanoma cells through recruiting TCF12 and activating NFAT5.
Lu F; Song Y; Cui S; Zhao H; Chen Y; Du H
Am J Transl Res; 2021; 13(11):12588-12600. PubMed ID: 34956475
[TBL] [Abstract][Full Text] [Related]
15. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
16. Partner of NOB1 homolog transcriptionally activated by E2F transcription factor 1 promotes the malignant progression and inhibits ferroptosis of pancreatic cancer.
Yang Q; Yang B; Chen M
Chin J Physiol; 2023; 66(5):388-399. PubMed ID: 37929351
[TBL] [Abstract][Full Text] [Related]
17. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
18. Histone demethylase KDM5D represses the proliferation, migration and invasion of hepatocellular carcinoma through the E2F1/TNNC1 axis.
Li L; Zhu G; Gong C; Hu M; Tan K; Jiang L; Li Y; Zhu X; Xie P; Chen X; Yang X
Antioxid Redox Signal; 2024 Mar; ():. PubMed ID: 38504588
[TBL] [Abstract][Full Text] [Related]
19. SET7/9 promotes hepatocellular carcinoma progression through regulation of E2F1.
Gu Y; Wang X; Liu H; Li G; Yu W; Ma Q
Oncol Rep; 2018 Oct; 40(4):1863-1874. PubMed ID: 30106440
[TBL] [Abstract][Full Text] [Related]
20. SIRT5 promotes cell proliferation and invasion in hepatocellular carcinoma by targeting E2F1.
Chang L; Xi L; Liu Y; Liu R; Wu Z; Jian Z
Mol Med Rep; 2018 Jan; 17(1):342-349. PubMed ID: 29115436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
